August 9, 2024 - 7:00am

Medicine is not immune to fashions and fads. But the British Medical Association’s (BMA) stubborn belief in the healing powers of puberty blockers is beginning to seem embarrassingly last season. Clinicians are now publicly distancing themselves from the outdated stance of their union, frustrated by the refusal of those at the top to acknowledge that the scientific consensus has moved on.

Last week, in a stunning display of obduracy, the BMA advised medics not to trust the findings of the Cass Review into NHS gender services for children. The inquiry by Cass, one of the world’s preeminent paediatricians, took four years to complete and the resulting report has been widely acknowledged as rigorous, robust and impartial.

But this was not enough for BMA chair Professor Philip Banfield. He announced the launch of the BMA’s own “task and finish” project to evaluate the findings of Cass’s research explaining the purpose of his report would be to “make recommendations to improve the healthcare system that has, for too long, failed transgender patients.” In the meantime, he suggested that the NHS continue to prescribe puberty blockers, despite the known risks and lack of any evidence of their efficacy. But not all of the BMA’s 195,000 members were in agreement.

Yesterday, an open letter from the Clinical Advisory Network on Sex and Gender (CAN-SG) addressed to Professor Banfield, warned that the organisation “is going against the principles of evidence-based medicine and against ethical practice” by refusing to accept the findings of the Cass Review. Signatories told the BMA chair: “We write as doctors to say, ‘not in my name’. We are extremely disappointed that the BMA council has passed a motion to conduct a ‘critique’ of the Cass review and to lobby to oppose its recommendations.”

It was not the only letter; another from Seen (Sex Equality and Equity Network) in Health urged the BMA to reconsider its stance “to ensure that the best interests of children and young people struggling with gender distress are at the forefront of policy and practice.”

Over the past few days, The Association of Clinical Psychologists UK (ACP-UK) and the Academy of Medical Royal Colleges have issued statements welcoming the Cass Review as a comprehensive analysis of the existing evidence. Indeed, earlier this week the NHS announced that it was putting Cass’s recommendations into practice, opening up to six centres to treat children who are confused about their gender in a holistic way. This includes a new clinic for those who have desisted or are detransitioning from their cross-sex or non-binary identities.

Traditionally, unions are supposed to represent their members. But it is becoming increasingly clear that the BMA is dangerously out of step with the medical consensus. The Cass Review has sent ripples across the world, and from lawsuits in the US to a change of tack across Europe — medics are increasingly acknowledging that what is a crisis in youth mental health cannot be cured by changing bodies.

Had a world leading clinician spent four years investigating childhood diseases or treatments for anxiety, the findings would be accepted without controversy. It is because the Cass Review sought scientific evidence for ideologically rooted treatments that her work has been dismissed by transgender activists, including clinicians like Prof Banfield. It seems so-called “gender medicine” is so mired in identity politics that scrutiny or the application of basic standards is considered a threat.

There can be few things more chilling than a medic on a messianic mission, particularly when one heads an institution as august as the British Medical Association (BMA). The trans trend is finally coming to an end, and if the BMA is to stay relevant, it must move on.


Josephine Bartosch is assistant editor at The Critic and co-author of the forthcoming book Pornocracy.

jo_bartosch